The global treating Brain Tumor Market was valued at USD 3.18 Billion in 2022, with projections indicating a climb to USD 5.07 Billion by 2032. Anticipated to maintain a compound annual growth rate (CAGR) of 6% throughout the forecast period, this growth is predominantly attributed to the escalating prevalence of brain tumors due to factors like population aging and exposure to environmental toxins.